期刊論文1. | 洪業晃、陳奕儒、陳明豐、楊基滐、朱彥璋(20061200)。甘草甜素對慢性C型肝炎血清生化值的臨床觀察。中西整合醫學雜誌,8(1),27-31。 延伸查詢![new window](/gs32/images/newin.png) |
2. | 胡志棠(20010500)。C型肝炎病毒與細胞交通。當代醫學,28(5)=331,73-79。 延伸查詢![new window](/gs32/images/newin.png) |
3. | 劉俊人、高嘉宏(20070900)。B型肝炎病毒基因型與病毒量之臨床意義。臺灣醫學,11(5),485-495。 延伸查詢![new window](/gs32/images/newin.png) |
4. | 高嘉宏、陳定信(19980600)。C型肝炎在臺灣。中華公共衛生雜誌,17(3),191-197。 延伸查詢![new window](/gs32/images/newin.png) |
5. | 郭佑啟(20020000)。C型肝炎。中化藥訊,53,17-21。 延伸查詢![new window](/gs32/images/newin.png) |
6. | 章振旺、朱正心、張文熊、陳逸洲(20061200)。C型肝炎相關之腎病變。內科學誌,17(6),259-263。 延伸查詢![new window](/gs32/images/newin.png) |
7. | 謝忠憲、朱宗信(20010500)。C型肝炎病毒相關的腎臟病變。臺灣醫學,5(3),352-356。 延伸查詢![new window](/gs32/images/newin.png) |
8. | Balachandran, S.、Roberts, P. C.、Brown, L. E.(2000)。Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection。Immunity,13,129-141。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
9. | Bantel, H.、Lugering, A.、Poremba, C.(2001)。Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection。Hepatology,34,758-767。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
10. | Barber, G. N.(2001)。Host defense, viruses and apoptosis。Cell Death Differ,8,113-126。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
11. | Barth, H.、Liang, T. J.、Baumert, T. F.(2006)。Hepatitis C virus entry: molecular biology and clinical implications。Hepatology,44,527-535。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
12. | Bowie, A. G.、Fitzgerald, K. A.(2007)。RIG-I: trying to discriminate between self and nonself RNA。Trends Immunol,28,147-150。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
13. | Brenner, C.、Grimm, S.(2006)。The permeability transition pore complex in cancer cell death。Oncogene,25,4744-4756。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
14. | Chiou, H .L.、Hsieh, Y. S.、Hsieh, M. R.、Chen, T. Y.(2006)。HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway。Biochem Biophys Res Commun,345,453-458。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
15. | Der, S. D.、Yang, Y. L.、Weissmann, C.、Williams, B. R.(1997)。A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis。Proc Natl Acad Sci USA,94,3279-3283。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
16. | Erickson, A. L.、Kimura, Y.、Igarashi, S.(2001)。The outcome of hepatitis C virus infection is predicted by escape mutation in epitopes targeted by cytotoxic T lymphocytes。Immunity,15,883-895。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
17. | Faouzi, S.、Burckhardt, B. E.、Hanson, J. C.、Campe, C. B.、Schrum, L. W.、Maher, J. J.(2001)。Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3- dependent pathway。J. Biol. Chem,276,4977-4982。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
18. | Fischer, R.、Schmitt, M.、Bode, J. G.、Haussinger, D.(2001)。Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells。Gastroenterology,120,1212-1226。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
19. | Fluda, S.、Debatin, K. M.(2002)。IFN gamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway。Oncogene,21,2295-2308。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
20. | Bantel, H.、Schulze-Osthoff, K.(2003)。Apoptosis in hepatitis C virus infection。Cell death and Differentiation,10,48-58。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
21. | Lee, S. K.、Park, S. O.、Joe, C. O.、Kim, Y. S.(2007)。Interaction of HCV core protein with 14-3-3 epsilon protein releases Bax to activate apoptosis。Biochem Biophys Res Commun,352,756-762。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
22. | Machida, K.、Cheng, K. T.、Lai, C. K.、Jeng, K. S.、Sung, V. M.、Lai, M. M.(2006)。Hepatitis C virus triggers mitochondria permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation。Virol,80,7199-7207。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
23. | Seeff, L. B.(2002)。Natural history of chronic hepatitis C。Hepatology,36,35-46。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
24. | Fischer, R.、Baumert, T.、Blum, H. E.(2007)。Hepatitis C virus infection and apoptosis。World J Gastroenterol,13(36),4865-4872。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
25. | Ferenci, P.、Fried, M. W.、Schiffman, M. L.、Smith, C. I.、Marinos, G.、Goncales, F. L.(2005)。Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin。Journal of Hepatology,43,425-433。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
26. | Stark, G. R.、Kerr, I. M.、Williams, B. R.、Silverman, R. H.、Schreiber, R. D.(1998)。How cells respond to interferons。Annu Rev Biochem,67,227-264。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
27. | Yoneyama, M.、Fujita, T.(2007)。Function of RIG-I-like receptors in antiviral innate immunity。J Biol Chem,282,15315-15318。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
28. | Strater, J.、Walczak, H.、Pukrop, T.(2002)。TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections。Gastroenterology,122,659-666。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
29. | Zhang, P.、Samuel, C. E.(2007)。Protein kinase PKR plays a stimulus and virus-dependent role in apoptotic death and virus multiplication in human cells。J Virol,81,8192-8200。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
30. | 李燕鳴(20040200)。基層醫療中C型肝炎之諮詢與防制。基層醫學,19(2),41-46。 延伸查詢![new window](/gs32/images/newin.png) |
31. | 許景盛、高嘉宏(20070900)。病毒性肝炎與代謝症候群。臺灣醫學,11(5),518-529。 延伸查詢![new window](/gs32/images/newin.png) |
32. | 曾光毅、曾嵩智、林佩璇(20040300)。現階段C型肝炎的預防與治療。基層醫學,19(3),61-66。 延伸查詢![new window](/gs32/images/newin.png) |
33. | 趙玉雯、吳義勇(20020200)。C型肝炎病毒感染于末期腎病接受透析病患及腎臟移植病患之近況趨勢。腎臟與透析,14(1),19-25。 延伸查詢![new window](/gs32/images/newin.png) |
34. | 蔡順隆(20030600)。B型與C型肝炎的免疫致病機轉。當代醫學,30(6)=356,437-448。 延伸查詢![new window](/gs32/images/newin.png) |
35. | Bartenschlager, R.(2006)。Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture。Curr Opin Microbiol,9,416-422。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
36. | Eichhorst, S. T.(2005)。Modulation of apoptosis as a target for liver disease。Expert Opin Ther Targets,9,83-99。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
37. | Deveraux, Q. L.、Reed, J. C.(1999)。IAP family proteins- suppressors of apoptosis。Genes Dev,13,239-252。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
38. | Weber, F.(2007)。Interaction of hepatitis C virus with the type I interferon system。World J Gastroenterol,13(36),4818-4823。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
39. | Gil, J.、Esteban, M.(2000)。Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action。Apoptosis,5,107-114。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
40. | Hiscott, J.(2007)。Triggering the innate antiviral response through IRF-3 activation。J Biol Chem,282,15325-15329。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
41. | Hopwood, M.、Treloar, C.(2005)。The experience of interferon-based treatments for hepatitis C infection。Qual Health Res,15(5),635-646。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
42. | Kubo, M.、Hanada, T.、Yoshimura, A.(2003)。Suppressors of cytokine signaling and immunity。Nat Immunol,4,1169-1176。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
43. | Kumar, S.(2007)。Caspase function in programmed cell death。Cell Death Differ,14,32-43。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
44. | Levy, D. E.、Darnell, J. E.(2002)。Stats: transcriptional control and biological impact。Nat Rev Mol Cell Biol,3,651-662。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
45. | Lindenbach, B. D.、Evans, M. J.、Syder, A. J.(2005)。Complete replication of hepatitis C virus in cell culture。Science,309,623-626。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
46. | Meylan, E.、Curran, J.、Hofmann, K.(2005)。Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus。Nature,437,1167-1172。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
47. | Samuel, C. E.(2001)。Antiviral actions of interferons。Clin Microbiol Rev,14,778-809。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
48. | Schaefer, U.、Voloshanenko, O.、Willen, D.、Walczak, H.(2007)。TRAIL: a multifunctional cytokine。Front Biosci,12,3813-3824。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
49. | Shuai, K.、Liu, B.(2005)。Regulation of geneactivation pathway by PIAS proteins in the immune system。Nat Rev Immurol,5,593-605。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
50. | 劉俊人、賴明陽(19981100)。慢性C型肝炎之治療。臺灣醫學,2(6),661-667。 延伸查詢![new window](/gs32/images/newin.png) |